Biomedical Engineering Reference
In-Depth Information
h
b
i
a
c
d
f
e
g
C 16 H 33
O
55 ° C
OH
C 16 H 33
N
O
C 16 H 33
O
e
45 ° C
i
O
13
c b
N
O
g
C 16 H 33
HO
d
f
h
35 ° C
O
C 16 H 33
a
10
25 ° C
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
(a)
(b)
55 C). Reprinted with permission from Ref.
[60b]. Copyright 2009 American Chemical
Society.
Figure 1.8 (a) Structure of gelator 10 .(b)
Variable temperature 1 H NMR spectra of 10
mg/ml 10 in C 6 D 6 in its gel phase (25 and
35 C) and its solution/sol phase (45 and
H
(a)
i
H i
H
H
g
O
H
N
O
H
a
c
H
f
I
H
O
N
N
e
H m
H
O O
b
H
d
11
H c
(c)
(b)
100˚C
90˚C
80˚C
70˚C
60˚C
50˚C
48˚C
46˚C
44˚C
42˚C
40˚C
37˚C
35˚C
30˚C
25˚C
100˚C
90˚C
80˚C
70˚C
60˚C
50˚C
48˚C
46˚C
44˚C
42˚C
40˚C
37˚C
35˚C
30˚C
25˚C
H
H a
H
CH 2
b
f
8
9
8
7
6
5
4
9
ppm
Figure 1.9 (a) Structure of leucine-based
gelator 11 . (b) Superimposition of 1 wt% 11
in toluene- d 8 1 H NMR spectra at different
temperatures (diphenylmethane as internal
standard). (c) Change of signals from the
two H c protons upon heating (in the rect-
angle). Intensities are normalized. Reprinted
with permission from Ref. [61c]. Copyright
2010 American Chemical Society.
 
Search WWH ::




Custom Search